Company news

QuidelOrtho Corporation news in 2022

QuidelOrtho Corporation's news releases, calls and decks from 2022, newest first.

View company

QuidelOrtho to Present at the J.P. Morgan Healthcare Conference

December 27, 2022

Health Canada Grants License for Quidel® TriageTrue® High-Sensitivity Troponin I Test to Aid in the Diagnosis of Myocardial Infarction

December 18, 2022

QuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® Platform

December 15, 2022

QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles

December 11, 2022

QuidelOrtho to Host Investor Day on December 13, 2022

November 29, 2022

QuidelOrtho Reports Third Quarter 2022 Financial Results

November 1, 2022

QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022

October 11, 2022

Development of New Drugs to Target Lyme and Other Infectious Diseases Subject of a New Webinar Now Available From Quidel Corporation

October 3, 2022

QuidelOrtho to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

September 5, 2022

Quidel and World Champion Los Angeles Rams Partner to Combat COVID-19 and Promote Health Awareness in the L.A. Community

August 31, 2022

Bacterial Biofilms, Responsible for Up to 75% of All Infectious Diseases in America, Explored in New Webinar From Quidel Corporation

August 23, 2022

QuidelOrtho Announces $300 Million Share Repurchase Authorization

August 16, 2022

QuidelOrtho Reports Second Quarter 2022 Financial Results

August 3, 2022

Ortho ranks No. 1 in customer satisfaction for 5 years in a row

July 25, 2022

QuidelOrtho to Report Second Quarter 2022 Financial Results on August 4, 2022

July 17, 2022

Quidel Corporation and the American Heart Association join forces to Advance Education and Awareness of Heart Disease in San Diego County

June 20, 2022

Quidel Corp.—Developer of Only FDA-Cleared FIA Rapid Point-of-Care Diagnostic Lyme Disease Test—To Partner With Renowned Global Lyme Alliance to Dramatically Heighten Lyme Disease Awareness

June 8, 2022

Quidel corp.—developer of only FDA-cleared fia rapid point-of-care diagnostic Lyme disease test—to partner with renowned Global Lyme Alliance to dramatically heighten Lyme disease awareness

June 8, 2022

QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics

May 26, 2022

Quidel and Ortho Announce Expected Closing of Ortho Transaction

May 25, 2022

Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination

May 15, 2022

Ortho Clinical Diagnostics Shareholders Approve Quidel Transaction

May 15, 2022

Quidel Reports First Quarter 2022 Financial Results

May 3, 2022

Quidel to Hold Fiscal First Quarter 2022 Financial Results Conference Call on May 4th, 2022

April 11, 2022

Quidel Announces Preliminary Revenue for First Quarter 2022

April 6, 2022

Quidel to Present at Raymond James 43rd Annual Institutional Investors Conference

February 27, 2022

Quidel Reports Fourth Quarter and Full Year 2021 Financial Results

February 16, 2022

Quidel to Hold Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call on February 17th, 2022

January 31, 2022

Quidel Announces Preliminary Revenue for Fourth Quarter 2021

January 5, 2022

The Signs, Diagnosis and Treatment of Lyme Disease Discussed as Part of New, On-Demand Webinar Hosted by Industry-Leading Quidel Corporation

January 4, 2022

Quidel to Present at 40th Annual J.P. Morgan Healthcare Conference

January 3, 2022

Calls in 2022

Decks in 2022